0.78
price down icon3.68%   -0.0298
after-market Handel nachbörslich: .78
loading

Salarius Pharmaceuticals Inc Aktie (SLRX) Neueste Nachrichten

pulisher
Dec 10, 2025

Salarius Pharmaceuticals Inc. (SLRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 10, 2025
pulisher
Dec 08, 2025

Taking the lead: Salarius Pharmaceuticals Inc (SLRX) - setenews.com

Dec 08, 2025
pulisher
Dec 06, 2025

Salarius Pharmaceuticals (NASDAQ:SLRX) Upgraded at Wall Street Zen - Defense World

Dec 06, 2025
pulisher
Dec 05, 2025

Why Salarius Pharmaceuticals Inc. stock is a must watch in 20252025 Trade Ideas & Real-Time Chart Breakout Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Can Salarius Pharmaceuticals Inc. (FP10) stock resist broad market declinesTrend Reversal & Accurate Entry/Exit Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Is Salarius Pharmaceuticals Inc. stock attractive for income investorsProduct Launch & Daily Entry Point Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Salarius Pharmaceuticals Inc. (FP10) stock sustain breakout momentumJuly 2025 Reactions & AI Powered Market Entry Ideas - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Salarius Pharmaceuticals (SLRX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 03, 2025
pulisher
Dec 02, 2025

How Salarius Pharmaceuticals Inc. (FP10) stock responds to job market shiftsWeekly Volume Report & Smart Money Movement Alerts - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Salarius Pharmaceuticals, Inc. (SLRX) 7.9% in After-hours: Collaboration with Texas Biomedical Research Institute Sparks Interest - Stocks Telegraph

Dec 01, 2025
pulisher
Dec 01, 2025

Salarius Pharmaceuticals' Decoy Unit Partners With Texas Biomed on Flu Inhibitor Testing - marketscreener.com

Dec 01, 2025
pulisher
Dec 01, 2025

Salarius Pharmaceuticals to collaborate with Texas Biomedical Research Institute on avian flu study - marketscreener.com

Dec 01, 2025
pulisher
Dec 01, 2025

SLRX Collaborates with Texas Research Institute for Influenza Te - GuruFocus

Dec 01, 2025
pulisher
Dec 01, 2025

Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study - GlobeNewswire

Dec 01, 2025
pulisher
Dec 01, 2025

Salarius (Nasdaq: SLRX) teams with Texas Biomed on H5N1 avian flu inhibitor testing - Stock Titan

Dec 01, 2025
pulisher
Nov 28, 2025

Will Salarius Pharmaceuticals Inc. stock benefit from infrastructure spending2025 Trade Ideas & AI Forecasted Entry and Exit Points - moha.gov.vn

Nov 28, 2025
pulisher
Nov 27, 2025

Is Salarius Pharmaceuticals Inc. stock affected by interest rate hikes2025 Price Action Summary & Consistent Profit Trading Strategies - moha.gov.vn

Nov 27, 2025
pulisher
Nov 25, 2025

Hanish of Salarius Pharma buys $3740 in shares - Investing.com India

Nov 25, 2025
pulisher
Nov 24, 2025

Hanish of Salarius Pharma buys $3740 in shares By Investing.com - Investing.com South Africa

Nov 24, 2025
pulisher
Nov 24, 2025

[Form 4] Salarius Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025
pulisher
Nov 24, 2025

What analysts say about Salarius Pharmaceuticals Inc stockDividend Yield Trends & Technical + Fundamental = Smarter Investing - earlytimes.in

Nov 24, 2025
pulisher
Nov 24, 2025

Salarius Pharmaceuticals Inc (SLRX) can make a big difference with a little luck - Setenews

Nov 24, 2025
pulisher
Nov 24, 2025

[Form 3] Salarius Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership - Stock Titan

Nov 24, 2025
pulisher
Nov 21, 2025

SLRX Stock Institutional Owners - Quiver Quantitative

Nov 21, 2025
pulisher
Nov 21, 2025

How Salarius Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Salarius Pharmaceuticals Exec VP Finance, CFO Mark J Rosenblum Acquires 20,000 Shares - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol SLRX - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Why Salarius Pharmaceuticals Inc. (FP10) stock stays resilientJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock Price Down 8.3% – Here’s Why - Defense World

Nov 20, 2025
pulisher
Nov 20, 2025

Will Salarius Pharmaceuticals Inc. (FP10) stock benefit from infrastructure bill - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Ranking Salarius Pharmaceuticals Inc. among high performing stocks via toolsProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

When is the best time to exit Salarius Pharmaceuticals Inc.Market Trend Summary & Free Weekly Watchlist of Top Performers - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What catalysts could drive Salarius Pharmaceuticals Inc. stock higher - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Applying Elliott Wave Theory to Salarius Pharmaceuticals Inc.Portfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Salarius clarifies Nasdaq listing status, refutes S&P CapIQ error By Investing.com - Investing.com Australia

Nov 19, 2025
pulisher
Nov 19, 2025

[8-K] Salarius Pharmaceuticals, Inc. Reports Material Event | SLRX SEC FilingForm 8-K - Stock Titan

Nov 19, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):